CollPlant Biotechnologies Ltd Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Expected Dividend
CollPlant Biotechnologies Ltd (CLGN) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Expected Dividend of $197.00 thousand for the 6-month period ending 2025-06-30, per its 6-K filed 2025-08-20.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend · last filed 2026-03-26
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Expected Dividend | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Expected Dividend 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Expected Dividend 12 month |
|---|---|---|---|
| 2025-06-30 | $197.00K 6-K · filed 2025-08-20 | ||
| 2024-12-31 | $579.00K 20-F · filed 2025-03-26 | ||
| 2023-12-31 | $579.00K 20-F · filed 2024-04-04 | ||
| 2023-08-23 | $579.00K 20-F · filed 2026-03-26 |